Ledger.Open graph →
SEC Form D · filed April 10, 2024

Algernon Pharmaceuticals Inc

Offering
$13K
Sold
$13K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Howard Gutman · Vancouver, British Columbia, CanadaDirectorRaj Attariwala · Vancouver, British Columbia, CanadaDirectorMark Williams · Vancouver, British Columbia, CanadaDirectorChristopher Moreau · Vancouver, British Columbia, CanadaExec · DirectorJames Kinley · Vancouver, British Columbia, CanadaExecChristopher Bryan · Vancouver, British Columbia, CanadaExecHarry Bloomfield · Vancouver, British Columbia, CanadaDirectorRaj Attariwala · Vancouver, British Columbia, CanadaDirectorHarry Bloomfield · Vancouver, British Columbia, CanadaDirectorChristopher Moreau · Vancouver, British Columbia, CanadaExec · DirectorChristopher Bryan · Vancouver, British Columbia, CanadaExecMark Williams · Vancouver, British Columbia, CanadaDirectorJames Kinley · Vancouver, British Columbia, CanadaExecHoward Gutman · Vancouver, British Columbia, CanadaDirectorJames Carr · Farmingdale, NJDirectorPatrick Flynn · Menlo Park, CADirectorDr. David Holtzman · St. Louis, MODirectorDr. Randall Bateman · St. Louis, MOExecTai Cripps · Birmingham, ALExecMicah Onixt · St. Louis, MOExec · DirectorDr. Joel Braunstein · St. Louis, MODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗